Check-Cap Ltd. logo
Check-Cap Ltd. CHEK
report update icon

Quarterly report 2025-Q4
added 11-14-2026

Check-Cap Ltd. Market Cap | CHEK

As of November 19, 2026 Check-Cap Ltd. has a market cap of $ 9.42 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Check-Cap Ltd.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 4.33 M 13.3 M 15.6 M 2.55 M 2.11 M 11.8 M 7.79 B 12.6 B 33.7 M 24.4 M - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
12.6 B 2.11 M 2.05 B

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Diagnostics research industry

Issuer Market Cap Price % 24h Market Cap Country
Enzo Biochem Enzo Biochem
ENZ
57.5 K - -8.98 % $ 14.8 K usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
22.7 M - 5.66 % $ 22.7 M britainBritain
DexCom DexCom
DXCM
25.5 B $ 82.53 0.6 % $ 32.2 B usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
1.38 B - - $ 1.49 B usaUSA
Heska Corporation Heska Corporation
HSKA
844 M - - $ 1.31 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
4.03 M - -61.36 % $ 2.46 M usaUSA
Celcuity Celcuity
CELC
5.37 B $ 55.51 -3.86 % $ 2.6 B usaUSA
T2 Biosystems T2 Biosystems
TTOO
7.78 M - -39.35 % $ 313 K usaUSA
Syneos Health Syneos Health
SYNH
9.41 B - - $ 4.46 B usaUSA
Biocept Biocept
BIOC
5.93 M - -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
511 M - - $ 21.2 M usaUSA
Quotient Limited Quotient Limited
QTNT
237 M - -11.32 % $ 1.1 M schweizSchweiz
DermTech DermTech
DMTK
42.4 M - -11.32 % $ 2.94 M usaUSA
Surmodics Surmodics
SRDX
554 M - - $ 608 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
301 M $ 9.02 -1.04 % $ 306 M israelIsrael
Akumin Akumin
AKU
75.1 M - -17.87 % $ 25.9 M canadaCanada
Psychemedics Corporation Psychemedics Corporation
PMD
16.8 M - -1.84 % $ 15.3 M usaUSA
Danaher Corporation Danaher Corporation
DHR
150 B $ 228.43 1.18 % $ 163 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
12.6 M - 0.22 % $ 16.8 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
990 K - -34.28 % $ 263 K israelIsrael
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
2.99 M - -20.0 % $ 1.06 M usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
104 K $ 2.72 1.87 % $ 88.3 K usaUSA
Biodesix Biodesix
BDSX
113 M $ 8.42 -5.18 % $ 63.6 M usaUSA
Agilent Technologies Agilent Technologies
A
31.5 B $ 176.32 2.38 % $ 50.1 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
7.95 M $ 0.98 3.13 % $ 5.34 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
2.95 B $ 12.85 2.8 % $ 135 M chinaChina
Bioventus Bioventus
BVS
608 M $ 10.64 0.38 % $ 709 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
23.3 B $ 259.18 1.1 % $ 28.8 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
7.69 B $ 333.37 0.36 % $ 16.5 B usaUSA
Guardant Health Guardant Health
GH
13.4 B $ 145.11 1.28 % $ 18.2 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
472 M $ 33.41 1.3 % $ 968 M usaUSA
Illumina Illumina
ILMN
25.3 B $ 209.18 3.24 % $ 32.4 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
28.3 B $ 257.93 0.13 % $ 44.3 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
23.9 B $ 370.49 0.61 % $ 30.8 B usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
51.1 B $ 700.79 1.53 % $ 56.4 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
13 B $ 647.03 -0.93 % $ 18.7 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
28.4 B $ 1 734.36 1.25 % $ 35.7 B schweizSchweiz
Natera Natera
NTRA
30.5 B $ 286.77 -0.25 % $ 39.2 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
5.12 B $ 102.03 0.23 % $ 6.89 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
527 M $ 25.14 3.84 % $ 774 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
993 M $ 74.4 -0.21 % $ 3.96 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
421 M - - $ 562 M britainBritain
Biomerica Biomerica
BMRA
6.09 M $ 1.15 -6.88 % $ 3.35 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
7.34 M $ 5.44 -9.42 % $ 24.1 M usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
481 M - 1.08 % $ 308 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
10.1 B $ 194.96 -0.03 % $ 15.3 B irlandaIrlanda
Senseonics Holdings Senseonics Holdings
SENS
351 M $ 9.76 -3.99 % $ 407 M usaUSA
Sotera Health Company Sotera Health Company
SHC
4.75 B $ 16.27 1.34 % $ 4.62 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
5.85 M $ 0.2 1.99 % $ 266 K usaUSA
Precipio Precipio
PRPO
38.4 M $ 18.8 -1.93 % $ 30.2 M usaUSA